Inflammatory Bowel Disease
Clinical research in ulcerative colitis and Crohn’s disease is a major focus, with attention to disease control, mucosal healing, and maintenance of remission in adults with moderate to severe inflammatory bowel disease.
- Ulcerative colitis
- Crohn’s disease
- Clinical remission
- Endoscopic response
These studies reflect interest in both induction and longer-term management of intestinal inflammation.
Respiratory Disease
The sponsor supports trials in asthma, including evaluation of rescue and maintenance treatment strategies for patients with persistent airway disease and related exacerbations.
- Asthma
- Rescue medication
- Severe exacerbations
- Airway inflammation
Research activity in this area centers on symptom prevention and control of acute respiratory worsening.
Neurology and Movement Disorders
Neurological research includes multiple system atrophy and migraine, with a focus on long-term tolerability, preventive treatment, and symptom reduction across adult and pediatric populations.
- Multiple system atrophy
- Migraine prevention
- Pediatric participants
- Chronic neurologic symptoms
These programs span both rare neurodegenerative disease and recurrent headache disorders.
Gastrointestinal and Immune-Mediated Conditions
Additional work addresses celiac disease and pruritus, extending the sponsor’s interest in immune-linked gastrointestinal disorders and symptom burden associated with inflammatory conditions.
- Celiac disease
- Gluten-induced enteropathy
- Pruritus
- Immune-mediated disease
These studies include both disease-specific and symptom-focused therapeutic areas.
Psychiatry and Healthy Participant Research
The portfolio also includes schizophrenia and studies in healthy participants, supporting work on psychiatric treatment exposure and foundational pharmacologic characterization.
- Schizophrenia
- Healthy participants
- Pharmacokinetics
- Drug absorption and metabolism
These trials broaden the sponsor’s therapeutic scope beyond disease-specific treatment into psychiatric and early human research settings.
